Companies

Music Licensing, Inc. Benefits from Listerine Royalty Payments

Published September 21, 2024

Naples, FL - September 20, 2024 - Music Licensing, Inc. SONG, a diversified holdings entity, recently announced a significant event that underscores its multifaceted investment strategy. The company confirmed the receipt of a royalty payment, marking a fruitful outcome of its stake in the renowned oral hygiene product, Listerine® Antiseptic Mouthwash. This revenue stream originates from the stake SONG holds in the well-established Listerine® brand, which enjoys a strong global presence and consistent consumer trust.

Royalty Revenue Boosts SONG Holdings

The influx of royalty payments is a positive signal for SONG shareholders, as it reflects the company's strategic acumen in selecting its investments. The ownership in a non-core but high-performing product such as Listerine® allows SONG to diversify beyond its primary focus, mitigating risk and enhancing the potential for stable, long-term returns. The payment adds to a series of strategic wins for SONG, showcasing its ability to identify and capitalize on unique investment opportunities.

Strategic Diversification: A Path to Stability

Music Licensing, Inc.'s approach extends beyond traditional assets, enabling the company to benefit from various market sectors. By receiving royalties from a product with an enduring legacy of effectiveness and brand loyalty like Listerine®, Music Licensing, Inc. fortifies its asset base. This diversification effort underlines the company's commitment to a robust investment philosophy aimed at delivering consistent value to its investors.

Naples, Royalty, Listerine